POZEN, Inc. (NASDAQ:POZN)

CAPS Rating: 3 out of 5

A pharmaceutical company focused on developing products which can provide improved efficacy, safety or patient convenience in the treatment of acute and chronic pain and pain related conditions.

Recs

0
Player Avatar eesirrius (< 20) Submitted: 7/15/2011 10:29:18 AM : Outperform Start Price: $4.58 POZN Score: +50.82

MFI Screen

Featured Broker Partners


Advertisement